Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
CDTX Cidara Therapeutics
- 23.9400
- +0.6100+2.61%
Close Feb 14 16:00 ET
- 23.9400
- 0.00000.00%
Post 20:01 ET
262.03MMarket Cap-1.03P/E (TTM)
24.3000High22.3400Low106.45KVolume23.2200Open23.3300Pre Close2.48MTurnover2.33%Turnover RatioLossP/E (Static)10.95MShares28.420052wk High2.27P/B109.49MFloat Cap10.000052wk Low--Dividend TTM4.57MShs Float382.6000Historical High--Div YieldTTM8.40%Amplitude8.0000Historical Low23.2560Avg Price1Lot Size
About Cidara Therapeutics Company
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
Company Profile
SymbolCDTX
Company NameCidara Therapeutics
Listing DateApr 15, 2015
Issue Price16.00
Founded2012
CEODr. Jeffrey Stein, PhD
MarketNASDAQ
Employees69
Fiscal Year Ends12-31
Address6310 Nancy Ridge Drive,Suite 101
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-752-6170
Websitehttp://www.cidara.com
Company Executives
- Name
- Position
- Salary
- Dr. Jeffrey Stein, PhD
- Director, President and Chief Executive Officer
- 1.56M
- Leslie Tari
- Chief Scientific Officer
- --
- Shane M. Ward
- Chief Operating Officer, Chief Legal Officer and Corporate Secretary
- 929.86K
- Dr. Preetam Shah, M.B.A.,PhD
- Chief Financial Officer, Chief Business Officer and Principal Accounting Officer
- --
- Daniel D. Burgess
- Chairman of the Board
- 126.84K
- Dr. James Merson, PhD
- Director
- --
- Dr. Josh Resnick, M.D.
- Director
- --
- Ryan Spencer
- Director
- --
- Chrysa Mineo
- Independent Director
- 91.34K
- Theodore R. Schroeder
- Independent Director
- 98.84K
- Carin Canale-Theakston
- Independent Director
- 82.34K
- Dr. Bonnie L. Bassler, PhD
- Independent Director
- 86.84K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.